Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2023-11-09 Capital/Financing Update
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Short Form Prospectus 19 pages 390.4KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Short Form Prospectus' and relates to an offer to transfer In-specie Shares pursuant to a Capital Reduction by way of an In-specie Distribution. It references the Corporations Act and ASIC lodgement, indicating it is a formal offering document. The content includes detailed terms and conditions of the Capital Reduction Offer, conditions precedent, and information for shareholders, which are typical elements of a prospectus used in capital raising or restructuring transactions. This is not a report of financial results, management discussion, or regulatory filing announcement, but a formal capital raising and share distribution document. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the actual prospectus, not just an announcement or notice.
2023-11-09 English
Long Form Prospectus 132 pages 3.5MB
Capital/Financing Update Classification · 100% confidence The document is titled 'Prospectus' and details an offer of shares by Reset Mind Sciences Limited, including priority offers, chair's list offers, and public offers with specific share quantities and prices. It references the Corporations Act 2001 (Cth), lodgement with ASIC, and includes detailed terms of the offer, risk factors, and other information typical of a prospectus used for capital raising. The document is not a report of financial results, management discussion, or regulatory filing but a formal offer document for new share issuance. This matches the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities. The document length is substantial and contains detailed offer information, not just an announcement or notice, so it is not an RPA or RNS. Therefore, the correct classification is CAP.
2023-11-09 English
Letter to Shareholders regarding Demerger & Priority Offer 2 pages 206.0KB
Capital/Financing Update Classification · 95% confidence The document is a shareholder letter dated 10 November 2023 from Little Green Pharma Ltd regarding a proposed demerger of its subsidiary Reset Mind Sciences Limited. It discusses the in-specie distribution of shares in Reset to existing shareholders and a priority offer for new shares in Reset. The document references a prospectus lodged with the Australian Securities and Investments Commission and provides details about the offer, record dates, and application instructions. There are no financial statements or detailed financial performance data included. The document is an announcement about a capital restructuring event and fundraising offer, not a full financial report or regulatory certification. Therefore, it fits best under Capital/Financing Update (CAP) as it updates shareholders on fundraising and capital structure changes related to the demerger and share offer.
2023-11-09 English
Quarterly Activities Report & Appendix 4C 18 pages 4.7MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'SEPTEMBER 2023 QUARTERLY ACTIVITIES REPORT AND APPENDIX 4C' and contains detailed financial and operational data for the quarter ending 30 September 2023. It includes revenue figures, cash receipts, segment revenue, net cashflows from operations, corporate updates, market updates, and operational progress. The presence of quarterly financial data and analysis, including revenue by product category and segment, cash flow information, and corporate changes, indicates this is a comprehensive quarterly report. The document is about 15,000 characters long, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2023-10-30 English
Change of Director's Interest Notice x 5 12 pages 396.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings and interests of company directors, including number of shares, options, and rights acquired or disposed. The document is a formal notification of personal share transactions by company directors. It does not contain financial performance data, earnings, or management discussion, nor is it an announcement of a report publication. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades).
2023-10-03 English
Application for quotation of securities - LGP 6 pages 28.4KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX by Little Green Pharma Ltd. It details the number and type of securities to be quoted, issue dates, and compliance with listing rules. There is no financial data, earnings information, or management discussion. The document is an announcement related to capital markets activity, specifically the quotation of new shares. This fits the category of Share Issue/Capital Change (SHA) as it concerns the issuance and quotation of additional shares.
2023-09-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.